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Evidence and knowledge gaps on the
disease burden in sexual and gender
minorities: a review of systematic reviews
Karel Blondeel1*, Lale Say2, Doris Chou2, Igor Toskin2,3, Rajat Khosla2, Elisa Scolaro2 and Marleen Temmerman1,2
Abstract
Sexual and gender minorities (SGM) include individuals with a wide range of sexual orientations, physical
characteristics, and gender identities and expressions. Data suggest that people in this group face a significant and
poorly understood set of additional health risks and bear a higher burden of some diseases compared to the
general population. A large amount of data is available on HIV/AIDS, but far less on other health problems. In this
review we aimed to synthesize the knowledge on the burden of communicable and non-communicable diseases,
mental health conditions and violence experienced by SGM, based on available systematic reviews. We conducted
a global review of systematic reviews, including searching the Cochrane and the Campbell Collaboration libraries, as
well as PubMed, using a range of search terms describing the populations of interest, without time or language
restrictions. Google Scholar was also scanned for unpublished literature, and references of all selected reviews were
checked to identify further relevant articles. We found 30 systematic reviews, all originally written in English. Nine
reviews provided data on HIV, 12 on other sexually transmitted infections (STIs), 4 on cancer, 4 on violence and 3
on mental health and substance use. A quantitative meta-analysis was not possible. The findings are presented in a
narrative format. Our review primarily showed that there is a high burden of disease for certain subpopulations of
SGM in HIV, STIs, STI-related cancers and mental health conditions, and that they also face high rates of violence.
Secondly, our review revealed many knowledge gaps. Those gaps partly stem from a lack of original research, but
there is an equally urgent need to conduct systematic and literature reviews to assess what we already know
on the disease burden in SGM. Additional reviews are needed on the non-biological factors that could
contribute to the higher disease burden. In addition, to provide universal access to health-care for all, more
information is needed on the barriers that SGM face in accessing health services, including the attitudes of
health-care providers. Understanding these barriers and the additional health risks they impose is crucial to
improving the health status of SGM.
Keywords: Sexual and gender minorities, Disease burden, LGBT, Health
Review
Background
The Constitution of the World Health Organization
(WHO) states that the “enjoyment of the highest attain-
able standard of health is one of the fundamental rights
of every human being without distinction of race, reli-
gion, political belief, economic or social condition” [1].
Although medical ethics require health services to be in-
clusive of all people, some populations have more
difficulties than others in reaching this standard of
health [2]. Those populations can be defined by age,
gender, race or ethnicity, geography, wealth, disability,
and also by sexual orientation and gender identity.
Populations defined by sexual orientation and gender
identity include individuals with a wide range of sexual
orientations, physical characteristics (as in intersex per-
sons), gender identities and expressions, all of which
they may experience differently depending on societal
gender norms and cultural traditions. For the purposes
of this article we have grouped men who have sex with
men (MSM), women who have sex with women (WSW),
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transgender and intersex persons, all defined by the Joint
United Nations Programme on HIV and AIDS
(UNAIDS), together under the name of ‘sexual and gen-
der minorities’ or SGM [3]. For research, health policy
and advocacy reasons, estimating the size of populations
of interest is important [4]. Due to stigma associated
with homosexuality and non-gender-normative behav-
iours, estimates of SGM populations are scarce, but
studies show that SGM comprise substantial proportions
of the population in countries worldwide [5–7].
Data suggest that SGM face a significant and poorly
understood set of additional health risks and bear a
higher burden of some diseases compared to the general
population [8, 9]. There have been international calls to
answer the unique health-care needs of SGM [10, 11]. It
is therefore indispensable to understand where we are
with the knowledge on the health burden of SGM. In
2002 Boehmer showed that research was limited in
scope, concentrating mostly on HIV and STIs and MSM
[12]. In high-income countries the research scope has
been broadening since, but the situation in middle- and
low-income countries is less clear [13]. In this review we
aimed to collate the knowledge and identify the know-
ledge gaps on the burden of communicable and non-
communicable diseases, mental health conditions and
violence experienced by SGM globally, based on avail-
able systematic reviews.
Methods
A review of systematic reviews can aim to bring together a
series of reviews on an important topic or summarize re-
views on a variety of topics with a common main theme
[14]. This review is of the latter type and while it is un-
likely to be of interest to clinicians and patients deciding
how best to address a specific problem, it may be relevant
to policy makers or to addressing questions that cut across
the different reviews [15]. The outcome of a review of re-
views is typically a summary of review results. Conducting
additional meta-analysis in a review of systematic reviews
is a major challenge due to the heterogeneity of the
methods, analyses and results of the original reviews.
Therefore meta-analysis is not a relevant method to this
review of systematic reviews and is descriptive in nature.
Search strategy
We conducted a review of systematic reviews in con-
cordance with the PRISMA statement [16]. The
Cochrane Database of Systematic Reviews and the
Campbell Collaboration Library of Systematic Reviews
were searched using the following terms to identify re-
views on the populations of interest: ‘gay’, ‘lesbian’, ‘trans-
gender’, ‘WSW’, ‘women who have sex with women’,
‘MSM’, ‘men who have sex with men’, ‘same sex’, ‘sexual
orientation’, ‘gender identity’, ‘sexual minority’, ‘intersex’ and
‘homosexuality’. We searched PubMed for the terms ‘sys-
tematic’ AND ‘review’ combined with a search strategy
(see Additional file 1) for sexual and gender minorities
(SGM). No language, time or geographical restrictions
were applied. The concept of ‘burden of disease’ was not
specified in search strategies. Google Scholar was searched
in English and references of the included reviews were
checked to identify further relevant articles.
Inclusion and exclusion criteria
Figure 1 shows how publications were selected for re-
view. Our initial search generated 399 publications.
Based on a review of the abstracts, the following exclu-
sions were made: duplicates, one publication lacking an
abstract, one protocol of a systematic review, publica-
tions that were not systematic reviews, publications
without data on disease burden, and publications with-
out data on SGM or with data on only a very specific
subset of SGM. We then retrieved and read the full text
of 50 retained publications. Those were all publications
we found on PubMed, the search on the Cochrane Data-
base of Systematic Reviews and the Campbell Collabor-
ation Library of Systematic Reviews did not generate
reviews of interest. Next, we further excluded national
reviews if they were included in larger reviews, and re-
views that were redundant due to newer published re-
views on the same subject and population. Twenty-five
articles were retained. An additional five eligible reviews
were identified from references and Google Scholar,
bringing the total to 30.
Quality assessment
The quality of the systematic reviews was assessed with
the AMSTAR scale (see Additional file 2) (http://
amstar.ca/). AMSTAR stands for A Measurement Tool
to Assess Systematic Reviews and was initially developed
to assess systematic reviews of randomised controlled
trials [17]. However, it is increasingly being used to as-
sess those that include observational studies as well. The
scale consists of 11 items. We considered systematic re-
views with a score from 0 to 3 as low quality, from 4 to
6 as medium quality, and from 7 up as high quality. The
AMSTAR score was not used as an exclusion criterium,
but used as an analytic tool. Regardless of the quality,
we did not find inconsistencies in the conclusions of the
included individual reviews.
Data extraction
We created a master table in Microsoft Excel containing
key information from each of the included reviews (see
Additional file 2): health topic, time range of the search,
year published, geographical scope, databases searched,
the SGM subpopulation, number of studies included,
measures, comparison groups, a summary of the
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quantitative and/or qualitative data on disease burden
and quality assessment score.
Results
All 30 reviews were originally written in English. Fifteen
reviews were global in scope, while 11 were regional and 5
were national. Nineteen reviews were exclusively or pre-
dominantly based on data from high-income countries.
Nine reviews provided data on HIV [6, 18–25], 12 on
other sexually transmitted infections (STIs) [21, 26–36], 4
on violence [37–40], 4 on cancer [32, 41–43] and 3 on
mental health and substance use [44–46]. One review pro-
vided data on both HIV and STIs [21]; another yielded
data on STIs as well as cancer [32]. Twenty-five reviews
provided data on MSM, 8 on WSW and 5 on transgender
persons (some reviews included more than one subpopu-
lation). Twenty-four studies compared data to the general
population or other groups, of which one half on the basis
of meta-analysis and the other half based on qualitative
observations. Fourteen reviews were considered high
Potentially relevant publications  
identified through search in 
PubMed (n=361)
Potentially relevant publications 
identified through search in the 
Cochrane Database of Systematic  
Reviews (n=13)
Potentially relevant publications 
identified through search in the 
Campbell Collaboration Library  
of Systematic Reviews (n=25)
Publications retained for further 
analysis, full text retrieved 
(n=50)
Publications excluded by title or abstract: 
– duplicates (n=6)
– not a systematic review (n=94)
– no SGM population (n=77)
– very specific SGM population (n=7)
– no data on disease burden (n=163)
– protocol of systematic review (n=1)
– no abstract available (n=1)
Publications excluded because of geographical 
scale, no new data or insufficient data (n=25)
Publications identified and included from lists 
of references and Google Scholar (n=5) 
Publications included in the 
review (n=30)
Fig. 1 Flowchart of inclusion criteria for reviews
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quality [6, 19, 20, 22, 23, 26, 27, 32, 36, 38, 42, 44–47], 9
medium quality [18, 24, 30, 31, 34, 35, 37, 39, 40] and 7
low quality [21, 25, 28, 29, 33, 41, 43]. We found no re-
views on intersex people. Detailed results are presented in
narrative form under five health topic sub-sections, by
SGM subpopulation, as shown in Table 1.
HIV/AIDS
Nine systematic reviews assessed the burden of HIV in
SGM, including 5 global and 4 regional reviews [6, 18–25].
Six of these reviews were on MSM, 2 were on male-to-
female transgender persons and 1 was on WSW.
Men who have sex with men (MSM) Among the 6 re-
views that provided data on MSM, 3 were exclusively on
MSM. One review was global [24] and 5 were regional
[6, 18, 19, 23, 25], of which 4 were mainly on low- and
middle-income countries (LMICs). Except for one re-
view from 2007, all were published in 2010 or later. All
reviews showed a high burden of HIV in MSM. The re-
gion with the highest HIV prevalence in MSM was the
Caribbean with 25.4 %, followed by sub-Saharan Africa
with 17.9 % [24]. In contrast, some countries in the Mid-
dle East and North Africa show very low HIV prevalence
in MSM [6]. In Asia, high rates of incident HIV-
infections in MSM were observed wherever studied [18],
and across the region of Latin America and the Carib-
bean MSM was the population most affected by HIV
[19]. MSM in LMICs have on average a 19.3 times
higher chance of being infected with HIV compared with
the general population [23]. In high-income countries,
Sullivan et al. showed that among new HIV cases, the
proportion attributed to male–male sex increased in all
the included countries between 2006 and 2011 [25].
Transgender persons Two systematic reviews, both of
high quality, provided data on HIV infection in male-to-
female transgender persons [20, 22]. The reviews were
global, collectively including studies from 20 countries.
One publication calculated an HIV prevalence of 14.7 %
in transgender persons who did not engage in sex work
and 27.3 % in those who did [20]. The second review
estimated a prevalence of 19.1 % and reported that this
population has a 48.8 times higher chance of being in-
fected with HIV than the general population of adults
aged between 15 and 49 [22]. We found no reviews on
HIV infection in female-to-male transgender persons.
Women who have sex with women (WSW) A low
quality systematic review on STIs in WSW globally did not
generate any HIV prevalence data in this population [21].
Sexually transmitted infections
Twelve systematic reviews included data on STIs other
than HIV in SGM, including 6 global, 4 regional and 2
national-level reviews [21, 26–36]. Nine of these reviews
were on MSM, 2 on WSW and 1 on MSM and trans-
gender persons.
MSM Three reviews reported on syphilis in MSM. Zoni
et al. showed high rates of active syphilis prevalence in
MSM in Latin America, with rates of 7.5 % or more in
half of the included studies [27]. In China, the median
syphilis prevalence, based on a review of four studies in
MSM, was 14.5 %, making MSM the group at highest
risk for syphilis in China [28]. Caceres et al. found that
syphilis prevalence among MSM in 16 LMICs ranged
from 1.5 % in Bangladesh to 29 % in Peru [35].
Hepatitis prevalence was reported in four reviews. A
2003 low quality global systematic review on hepatitis A
virus (HAV) did not find an important difference in
anti-HAV positivity between MSM and control groups
[29]. Two reviews on hepatitis B and C viruses (HBV
and HCV) in Europe presented disaggregated data for
MSM [30, 31]. One showed higher hepatitis C virus anti-
bodies and hepatitis B surface antigen prevalence than in
the general population, based on three country estimates
[30]. In LMICs, data on HBV prevalence was even
sparser. With rates of HBV up to 38 % in Argentina and
31 % in Vietnam, MSM seem to be a high-risk group
[35]. A global review comparing incidence of acute HCV
in HIV-negative versus HIV-positive MSM found that
the incidence in the latter group was four times higher;
the incidence rates in HIV-negative MSM were similar
Table 1 Number of reviews selected, by health topic and subpopulation
Health topic Men who have sex with
men (MSM)
Women who have sex with
women (WSW)
Transgender
persons
Total number
of reviews
HIV/AIDS 6 1 2 9
STI 10 2 1 12
Cancer 3 1 0 4
Mental health and substance use 2 2 1 3
Violence 4 2 0 4
Total 25 8 5 30
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to heterosexual populations [36]. The Pan American
Health Organization (PAHO) is currently conducting a
review of hepatitis B and C in the countries of the
Americas; so far the findings point to a higher burden
for MSM (personal communication, Rafael Mazin, focal
point for HIV/STIs and hepatitis in key populations,
PAHO, 30 May 2014).
In one low quality global review, prevalence of herpes
simplex virus 2 (HSV-2) was demonstrated to be higher
among male homosexual than among male heterosexual
populations [33].
Chlamydia trachomatis and Neisseria gonorrhoeae
have not been the subject of global systematic reviews in
SGM. One review reported data from nine LMICs with
prevalence rates ranging from 0 % (Peru) and 2.1 %
(Nepal) up to 14.9 % and 16.1 % (both in Timor-Leste)
[35]. A national review on C. trachomatis in Australia
designated MSM amongst the populations with the
greatest burden, calculating a pooled prevalence for rec-
tal C. trachomatis of 5.6 % [34].
In a high quality global systematic review, Machalek
et al. showed a pooled prevalence of any type of anal hu-
man papillomavirus (HPV) of 53.6 % in HIV-negative
MSM and 89.0 % in HIV-positive MSM [32]. High-grade
anal intraepithelial neoplasia was present in 20–30 % of
all MSM [32].
WSW Two global systematic reviews on bacterial vagin-
osis and on STIs in WSW showed a positive association
between a history of female sexual partners and risk of
bacterial vaginosis [21, 26]. There was no evidence of a
higher burden of STIs in WSW compared with the gen-
eral population of adult women [21].
Transgender persons Zoni et al. found syphilis preva-
lence rates ranging from 6.5 % in El Salvador to 43.3 %
in Brazil, the latter being the highest rate among high-
risk populations (MSM, sex workers and transgender
persons) in Latin America and the Caribbean [27]. Pre-
liminary results of an ongoing review on hepatitis B and
C by PAHO in the region of the Americas show a higher
burden for male-to-female transgender persons (per-
sonal communication, Rafael Mazin, focal point for
HIV/STIs and hepatitis in key populations, PAHO, 30
May 2014).
Cancer
Four reviews, two high and two low quality, included
data on cancer in SGM; all were global in scope [32, 41–
43]. Three of these reviews were in MSM and 1 in
WSW; no reviews were found on cancer burden in
transgender persons.
MSM Anal HPV is common in MSM, as are HBV and
human herpesvirus 8 (HHV-8) infections. These viruses
can lead to anal cancer, liver cancer and Kaposi sarcoma,
respectively. One review considered MSM at high risk
for anal cancer, and found that HIV-positive MSM were
at highest risk [43]. Systematic reviews on HPV and on
cancer in general in MSM found that HIV-positive
MSM had a high incidence of anal cancer, similar to the
incidence of cervical cancer in the general female popu-
lation before the introduction of national cervical
screening programmes [32, 41]. Boehmer et al. found
that only 1 of the 47 studies included in their review on
cancer in MSM was not linked to STIs [41].
WSW Meads & Moore systematically reviewed studies
on breast cancer in lesbian and bisexual women. This re-
view included nine studies with prevalence estimates, of
which two showed higher prevalence of breast cancer in
lesbian and bisexual women then in heterosexual
women, four showed no difference, one showed mixed
results and two could not be compared. Though the re-
view was of high quality, all the included studies were
small and of poor quality. The reviewers concluded that
there was no convincing evidence of a higher disease
burden of breast cancer in WSW [42].
Mental health and substance use
Three high quality reviews – 2 global and 1 national –
provided data on mental health and substance use in
SGM [44–46]. Two of these were in MSM and WSW
while 1 was in transgender persons.
MSM and WSW In their global review, King et al. cal-
culated an overall 2.47 times increased risk of lifetime
suicide attempts in lesbian, gay and bisexual (LGB)
people compared to heterosexuals; the risk ratio for life-
time suicidal ideation was 2.04, and it was 2.05 for
12 months prevalence of depression, one of the most
common mental illnesses [45]. The reviewers also calcu-
lated a pooled risk ratio of 1.88 in gay and bisexual
males for 12 months prevalence of anxiety disorders
(specific disorders were not specified), but the results for
lesbian and bisexual females were less convincing due to
heterogeneity in the study methods (I2 = 49.2 %). The re-
view also found that alcohol and substance dependence
were at least 1.5 times more common in these popula-
tions than in the heterosexual population. Marshal et al.
calculated that the odds for substance use among LGB
youth globally were 190 % higher than for heterosexual
youth [46].
Transgender persons We found data on mental health
in transgender persons in a systematic review on the
prevalence of HIV and contextual factors potentially
Blondeel et al. International Journal for Equity in Health  (2016) 15:16 Page 5 of 9
associated with HIV risk in the United States of America
(USA). High rates of suicidal thoughts (weighted mean,
53.8 %) and lifetime suicide attempts (weighted mean,
31.4 %) were reported in male-to-female transgender
persons [44].
Violence
Violence is one of the more visible health issues in
SGM, and the subject of many advocacy efforts. We
found four systematic reviews on the prevalence of vio-
lence in SGM, including 1 global, 1 regional (North
America and Europe) and 2 national-level reviews (USA)
[37–40]. All four were on LGB people; there were no re-
views on violence in transgender persons.
MSM and WSW A global review found high rates of
physical assault (28 %) and sexual assault (27 %) in LGB
individuals, and suggested that they experience more
victimization than heterosexuals [37]. Peterson et al.
concluded that rates of adult sexual assault among gay
and bisexual males in North America and Europe far ex-
ceed the rates in community samples of men [40]. LGB
people in the USA seem to be at increased risk for sex-
ual violence victimization compared with their hetero-
sexual counterparts [38]. Focusing on the subset of
intimate partner violence, Finnerman & Stephenson
concluded that emergent evidence in the USA demon-
strates that prevalence of intimate partner violence is
high in male–male partnerships [39].
Discussion
Our review found that HIV and STIs are the most
researched topics for those studying the disease burden
in SGM, and that the subpopulation of MSM is the most
intensively studied.
The six included reviews on HIV in MSM (all pub-
lished in 2007 or later) show a high burden in this popu-
lation. UNAIDS reports that the median HIV prevalence
among MSM exceeds 1 % in all regions of the world and
is substantially higher than prevalence among men over-
all, in every context studied [47]. Furthermore, there is
no evidence of a decline in the HIV epidemic in MSM
[18, 24, 47]. HIV prevalence among MSM in some low-
income countries could be underreported because the
data are too limited; male same-sex sexual behaviour
takes multiple forms and HIV has huge potential to in-
crease further in MSM in the next decade [48, 49]. Abu-
raddad et al. indicated growing – in some cases rapidly
growing – HIV epidemics in MSM in several countries,
including Egypt, Morocco, Pakistan, Sudan, Tunisia and
Yemen [49]. Systematic reviews of the existing research
of HIV burden in MSM seem to be up to date and of
reasonable quality, though original research and data are
still lacking in many countries.
Limited research on HIV in male-to-female trans-
gender persons suggests a high burden. For WSW, a re-
view generated no results but was low in quality [21].
For female-to-male transgender persons and intersex
people we found no reviews. The feasibility of conduct-
ing a systematic review on disease burden of HIV in
these populations should be investigated.
Reviews on STIs reported a high burden of syphilis in
MSM in Latin America, China and LMICs where preva-
lence was measured. A report by the European Surveil-
lance of Sexually Transmitted Infections (ESSTI)
network confirms that MSM also bear a disproportion-
ate burden of syphilis across Western Europe and that
there is clear evidence that it has increased considerably
[50]. Syphilis has been identified as a growing problem
among MSM in a number of countries, based on the
Global AIDS Response Progress Reports [51].
HAV burden was not found to be higher in MSM
compared to heterosexual men in high income countries
[29], but a more recent report on viral hepatitis in Euro-
pean MSM did show an elevated prevalence [52]. In-
creasing attention is being paid to HBV as an STI in
MSM. While a 2004, non-sysytematic, review on disease
burden of HBV only mentioned homosexual activity as
one of the risk factors, alongside heterosexual activity
[53], a more recent epidemiological report estimated
that HBV incidence among MSM is 20 times higher
than in the general population [52]. The same report
also looked at HCV, but did not clarify whether its high
burden was only in HIV-positive MSM or in MSM in
general [52].
A 2014 protocol for a global systematic review on the
prevalence of HHV-8 described the investigators’
intention to examine the hypothesis that MSM have a
high prevalence of the HHV-8 antibody – the infectious
disease underlying Kaposi sarcoma – and to determine if
the prevalence is increasing [54]. The results have not
been published yet.
Our results suggested a high burden of C. trachomatis
in MSM, based on sparse data from medium quality re-
views [34, 35]. Moreover, the most recent annual epi-
demiological report of the European Centre for Disease
Prevention and Control (ECDC), published in 2013, in-
dicated that 99 % of cases of the L2b variant of C.
trachomatis, which causes the majority of lymphogranu-
loma venerum infections, are in MSM [55]. Among
those cases with known HIV status, 88 % were HIV-
positive.
Data from systematic reviews on the burden of N.
gonorrhoeae in SGM were too scarce to support any
conclusions, but an ESTTI report suggested that MSM
bear a disproportionate burden of gonococcal infection
in many Western European and some Central and East-
ern European countries [50]. The ECDC report also
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indicated that among all N. gonorrhoeae cases diagnosed
in men in Europe in 2011, 53 % were in MSM [55].
Moreover, there are indications that MSM are one of the
core groups that are key to the emergence, onward
transmission and outbreaks of antimicrobial-resistant N.
gonorrhoeae [56].
The burden of anal HPV is well documented in MSM;
the review by Machalek at al. showed high prevalence in
MSM in general and very high prevalence in HIV-positive
MSM in particular [32]. We found no review on the
prevalence of oral HPV, though studies show it is high in
MSM, and is a risk factor for oropharyngeal cancer [57].
The systematic review on STI/HIV in WSW did not
show a higher burden in this population [21]. Nonethe-
less, the authors concluded that WSW should not be
presumed to be at lower risk based on their sexual
orientation, since they can acquire HIV and other STIs
through other modes, including injection drug use and
sexual contact with high-risk male partners.
Available research on cancer burden in MSM focuses
mainly on cancers that are causally linked to STIs; most
other cancers have yet to be studied in this subpopula-
tion [41]. Lee et al. showed that there might be reason
to believe there are also disparities in other cancers, as
sexual minorities in the USA are 1.5 to 2.5 times more
likely to be smokers than the heterosexual population
[58]. Smoking is a major risk factor for lung cancer and
a risk factor for a myriad of other cancers.
Mental health is a poorly reviewed health issue in
SGM. The most recent global systematic review on men-
tal health in SGM, although high quality, dated from
2008 and suggested an elevated burden in a variety of
mental health issues, but it did not include transgender
persons [45]. Eating disorders and obesity were not dis-
cussed, although they are mentioned in a review on the
health of SGM by the United States Institute of Medi-
cine [9]. Regarding substance use, we found that sexual
orientation is an important mediating factor of adoles-
cent substance use [46]. Adding to this, Bourne et al.
conducted a global literature review on drug use in
MSM and concluded that the prevalence of drug use is
high [59]. Some party drugs used by MSM, such as crys-
tal methamphetamine or gamma-butyrolactone, can
have detrimental effects on mental and sexual health (an
internet survey in Asia reported 4 % and 2.3 % use in
MSM, respectively, in the last six months) [59].
Lastly our results show that MSM and WSW are con-
fronted with more violence than their heterosexual
counterparts. However, most of the studies were from
the USA and other high-income countries; we might ex-
pect to see even higher rates of violence in SGM in
countries where homosexuality is criminalized. A study
from the USA on violence in transgender persons
assessed self-report surveys and needs assessments,
hotline calls, social service records and police reports
[60]. All these sources indicated that violence against
transgender persons starts early in life, that they are at
risk for multiple types and repeated incidents of vio-
lence, particularly sexual violence, and that this threat
lasts throughout their lives.
Except for the reviews that reported on cancer and
mental health, there are no systematic reviews on non-
communicable diseases in SGM. Nevertheless, there is a
growing body of research on the health of SGM. We
analysed data from systematic reviews only; therefore
the results of research that have not yet been included in
a systematic review are not reflected in this article. More
extensive reporting, which includes the results of these
studies and of studies on risk, contextual and contribut-
ing factors of health disparities and specific health issues
in SGM, is beyond the scope of this review. Methodo-
logically, this review is limited by the databases we
searched and the use of exclusively English search terms
on Google Scholar.
Conclusions
Our review primarily shows that there is a high burden
of disease for certain subpopulations of SGM in HIV,
STIs, STI-related cancers and mental health conditions,
and that they also face high rates of violence. Secondly,
our review revealed many knowledge gaps. Those gaps
partly stem from a lack of original research, which needs
to be addressed, but there is an equally urgent need to
conduct high quality systematic and literature reviews to
assess what we already know on the disease burden in
SGM.
We recommend that systematic reviews on HIV and
HPV in MSM be regularly updated. Reviews on herpes
in MSM, STIs in WSW, and on mental health, violence
and substance use in MSM and WSW, urgently need to
be updated. Special attention should be given to violence
based on sexual orientation and gender identity. Global
reviews on syphilis, hepatitis, C. trachomatis and N.
gonorrhoeae in MSM, and on all of the most common
STIs, mental health and violence in the transgender
population need to be conducted. In particular, research
on female-to-male transgender persons should be con-
sidered, as there are virtually no epidemiologic data on
the burden of disease in this population. Literature re-
views should include publications on the burden of can-
cers that are not related to infectious causes and other
non-communicable diseases in all SGM. It would facili-
tate this process if health research, surveys and statistical
databases systematically included sexual orientation and
gender identity as a demographic characteristic, where
possible. There is also a geographical research gap since
most of the systematic reviews included studies that
were all or mostly from high-income countries. New
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reviews could capture research from LMICs by broaden-
ing and deepening search strategies. The quality of the
systematic should also improve, as less than half were of
high quality,
The majority of the currently available systematic reviews
are on MSM and the burden of HIV and STIs. This sug-
gests that a substantial portion of the burden of disease in
SGM is related to their sexual behaviours, which means it
is preventable. WHO and UNAIDS have been building on
that knowledge, issuing guidelines, recommendations and
tools, including tools for estimating the numbers of specific
populations, and for monitoring and evaluating policies and
interventions to remediate the burden of HIV and STI in
these populations [2, 61–63]. Additional reviews should be
conducted on the non-biological factors that contribute to
higher disease burden. In order to provide universal access
to health-care, more knowledge is needed on the barriers
that SGM face in accessing health services, including the at-
titudes of health-care providers, who are ethically bound to
provide good quality services, regardless of the personal
history or characteristics of the patient. Understanding
these barriers and the additional health risks they impose is
crucial to improving the health status of SGM.
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